80 likes | 88 Views
The adoption of transplant diagnostics (including both pre- and post-transplant screening) is expected to witness a significant rise with increasing prevalence of chronic diseases that can lead to organ failure.
E N D
Transplant Diagnostics Market - Global Opportunity Analysis & Industry Forecast 2020- 2027
Transplant Diagnostics Market by Molecular and Non-Molecular Assay Technology (Serological assay, Mixed Lymphocyte Culture, PCR Based, Sequencing Based), End-User (Hospitals and transplant centers, Research laboratories and academic institutes, Commercial Service Providers) - Global Opportunity Analysis and Industry Forecast, 2020 - 2027 Transplant Diagnostics Market - Global Opportunity Analysis & Industry Forecast 2020- 2027
Transplant Diagnostics Market - Overview: Increase in incidence of organ failure owing to growing cases of chronic diseases, rise in ageing population, and increase in focus on R&D is expected to propel the growth of the global transplant diagnostics market. Chronic diseases can lead to organ failure in patients, which could be a significant target audience for transplant diagnostics procedures. However, difficulties in human leukocyte antigen (HLA) sequencing and increasing worldwide organ shortage can hamper the market growth.
Transplant Diagnostics Market - Major Key Players • Major players operating in the market include Immucor, Inc. (TGI Capital), Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc. F. Hoffmann-la Roche AG, Illumina Inc., Abbott Laboratories, Sigma-Aldrich Corporation, Qiagen N. V., Olerup SSP AB (Allenex), and Diasorin S.P.A. Thermo Fisher occupies. Read More@ https://www.alliedmarketresearch.com/transplant-diagnostics-market
Transplant Diagnostics Market & COVID-19 COVID-19 Scenario: • Due to the global pandemic all over the world, the medical devices manufacturers are majorly focusing on essential medical devices production including ventilators and diagnostics. • However, due to the precautionary measures taken by governments in various regions, the supply chain has been hampered. Which may result in shortage of devices in certain locations. • Food and Drugs Administration (FDA), on the other hand, shared a COVID-19 guidance with medical device manufacturers to notify the agency about changes that could affect availability of their products. Get detailed COVID-19 impact analysis on the Market@ https://www.alliedmarketresearch.com/request-for-customization/1135?reqfor=covid
Veterinary Medicine Market – Regional outlook The market is evaluated based on its regional penetration, explaining the performance of the market in each regional market covering regions such as North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Get Free Sample PDF of Report@ https://www.alliedmarketresearch.com/request-sample/1135
About Us:- Allied Market Research (AMR) is a market research and business-consulting firm of Allied Analytics LLP, based in Portland, Oregon. AMR offers market research reports, business solutions, consulting services, and insights on markets across 11 industry verticals. Adopting extensive research methodologies, AMR is instrumental in helping its clients to make strategic business decisions and achieve sustainable growth in their market domains. We are equipped with skilled analysts and experts, and have a wide experience of working with many Fortune 500 companies and small & medium enterprises. Visit Or Website@ https://www.alliedmarketresearch.com
Contact Us: • David Correa • 5933 NE Win Sivers Drive • #205, Portland, OR 97220 • United States • USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141 • UK: +44-845-528-1300 • Hong Kong: +852-301-84916 • India (Pune): +91-20-66346060